Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.verified

NWBO

Price:

$0.26

Market Cap:

$337.34M

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.[Read more]

Industry

Biotechnology

IPO Date

2001-12-14

Stock Exchange

PNK

Ticker

NWBO

The ROE as of December 2024 (TTM) for Northwest Biotherapeutics, Inc. (NWBO) is 134.02%

According to Northwest Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 134.02%. This represents a change of 295.00% compared to the average of 33.93% of the last 4 quarters.

Northwest Biotherapeutics, Inc. (NWBO) Historical ROE (quarterly & annually)

How has NWBO ROE performed in the past?

The mean historical ROE of Northwest Biotherapeutics, Inc. over the last ten years is 367.24%. The current 134.02% ROE has changed -63.51% with respect to the historical average. Over the past ten years (40 quarters), NWBO's ROE was at its highest in in the September 2016 quarter at 581.98%. The ROE was at its lowest in in the December 2021 quarter at -107.52%.

Quarterly (TTM)
Annual

Average

367.24%

Median

140.79%

Minimum

-144.47%

Maximum

2.45%

Northwest Biotherapeutics, Inc. (NWBO) ROE by Quarter and Year

Discovering the peaks and valleys of Northwest Biotherapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 533.69%

Maximum Annual ROE = 2.45%

Minimum Annual Increase = -197.39%

Minimum Annual ROE = -144.47%

Quarterly (TTM)
Annual
YearROEChange
2023133.26%24.74%
2022106.83%-173.95%
2021-144.47%-197.39%
2020148.33%174.15%
201954.11%-28.72%
201875.90%-50.92%
2017154.66%-48.91%
2016302.71%-87.66%
20152.45%533.69%
2014387.23%-42.21%

Northwest Biotherapeutics, Inc. (NWBO) Average ROE

How has NWBO ROE performed in the past?

The current ROE of Northwest Biotherapeutics, Inc. (NWBO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

31.87%

5-year avg

59.61%

10-year avg

367.24%

Northwest Biotherapeutics, Inc. (NWBO) ROE vs. Peers

How is NWBO’s ROE compared to its peers?

Northwest Biotherapeutics, Inc.’s ROE is greater than ImmunoCellular Therapeutics, Ltd. (0%), greater than Celldex Therapeutics, Inc. (-21.49%), greater than CEL-SCI Corporation (-233.88%), greater than OncoSec Medical Incorporated (-154.68%), less than Advaxis, Inc. (411.93%),

Build a custom stock screener for Northwest Biotherapeutics, Inc. (NWBO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Northwest Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Northwest Biotherapeutics, Inc. (NWBO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Northwest Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Northwest Biotherapeutics, Inc.'s ROE?

How is the ROE calculated for Northwest Biotherapeutics, Inc. (NWBO)?

What is the highest ROE for Northwest Biotherapeutics, Inc. (NWBO)?

What is the 3-year average ROE for Northwest Biotherapeutics, Inc. (NWBO)?

What is the 5-year average ROE for Northwest Biotherapeutics, Inc. (NWBO)?

How does the current ROE for Northwest Biotherapeutics, Inc. (NWBO) compare to its historical average?